FDA “Credibility,” “Authority” Threatened By State Imports, PhRMA Says
Executive Summary
FDA needs to take action against state and local governments that encourage drug importation, Pharmaceutical Research & Manufacturers of America Assistant General Counsel Scott Lassman told a Food & Drug Law Institute audioconference Dec. 16
You may also be interested in...
Rx Import Law Likely In ‘04, AARP’s Rother Says; FDA Thinks States Will Wait
Congress will pass prescription drug importation legislation in 2004 as a "bridge" to the Medicare drug benefit in 2006, AARP Policy & Strategy Director John Rother predicted during a Kaiser Family Foundation webcast Dec. 2
Reimportation Limits Remain In Medicare Agreement; HHS Study Requested
HHS would conduct a study of the safety issues associated with drug reimportation under the Medicare Rx benefit 1conference agreement released Nov. 20
Canadian Rx Import Business Is Illegal, Court Finds In Granting FDA Injunction
Rx Depot will be required to send a letter to customers indicating that the firm has violated the law under a Tulsa federal court order